>
Powered by

Arch Biopartners plummets 16.7% on robust volume March 03, 2017 17:00 EST

Mar 3, 2017 - News Bites Canadian Markets

CANADIAN DAILY STOCK REPORT

Arch Biopartners Inc. (TSXV:ARCH), Canada's 36th largest Biotechnology company by market cap, has plummeted 8.0c (16.7%) from its last trading session of March 02 to close at 40.0c. Compared with the S&P/TSX 60 Index which rose 4.4 points (0.5%) in the day, the relative price change was -17.1%. The fall was exacerbated by robust volume of 1.9 times the average daily volume of 9,498 shares.

SECTION 1

ARCH BIOPARTNERS BEARISH SIGNALS

1.1 Fundame

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox